Pathophysiology and Pharmacotherapy of Cardiovascular Disease 2015
DOI: 10.1007/978-3-319-15961-4_5
|View full text |Cite
|
Sign up to set email alerts
|

Sympathetic Nervous System Signaling in Heart Failure and Cardiac Aging

Abstract: Heart failure represents the leading cause of death, especially among the elderly. Despite the development of numerous therapeutic strategies, heart failure prevalence is still increasing. Ergo, exploring the molecular mechanisms underlying aging-related heart failure seems to be of particular relevance. Intriguingly, the fi elds of cardiovascular disease and aging, which have remained largely separate hitherto, seem to have a common point in the sympathetic nervous system. Indeed, mounting evidence indicates … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
8
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 9 publications
(9 citation statements)
references
References 135 publications
(74 reference statements)
1
8
0
Order By: Relevance
“…Hyperactivation of sympathetic nervous system in HF is initially compensatory, but eventually accelerates the progression of the disease, posing severe toxicity on the chronically failing heart [107,108,111]. In this sense, the beneficial effects of AR blockers and other therapeutic approaches that mitigate or protect the heart against this sympathetic overdrive are well documented [108,112,113].…”
Section: Ryr2 and Heart Failurementioning
confidence: 99%
“…Hyperactivation of sympathetic nervous system in HF is initially compensatory, but eventually accelerates the progression of the disease, posing severe toxicity on the chronically failing heart [107,108,111]. In this sense, the beneficial effects of AR blockers and other therapeutic approaches that mitigate or protect the heart against this sympathetic overdrive are well documented [108,112,113].…”
Section: Ryr2 and Heart Failurementioning
confidence: 99%
“…Our present findings add a novel mechanism for OPN’s pro-fibrotic effects, at least in the heart— interference with the anti-fibrotic actions of the catecholamines through the β 2 AR. In contrast to the β 1 AR, the β 2 AR is considered cardio-protective in the post-MI failing heart, since it can facilitate infarct (wound) healing; promote cardiomyocyte survival; and limit inflammation, apoptosis, and other adverse remodeling processes that ensue immediately after an MI [4,39,40]. Indeed, cAMP and its effector Epac1—which are induced by the activated β 2 AR in the heart—are known to exert anti-fibrotic effects in several cell types and tissues, including in the heart [16].…”
Section: Discussionmentioning
confidence: 99%
“…Adrenergic receptors (ARs) belong to the family of G protein-coupled receptors (GPCRs). Reportedly, ARs are involved in aging and cardiovascular physiopathology (15). In response to stimulation of the sympathetic nervous system, α 1 ARs (α 1A , α 1B and α 1D ) are able to activate Gα q , which contributes to cardiac remodeling (16).…”
Section: Discussionmentioning
confidence: 99%